I’m a basic science researcher with more than 15 years of experience investigating the virus-host interactions and signaling pathways essential for the emergence of HIV from latency in primary T cells. My major research accomplishments over the last 10 years have been: 1) Delineation of the signaling pathways in primary T cells and intermolecular interactions that critically regulate the biogenesis of P-TEFb, a transcription elongation factor necessary for stimulating HIV transcription elongation; 2) Mechanistic characterization of RasGRP1 agonists as a novel class of agents that can reverse HIV latency with minimal undesirable cellular responses; and 3) Development of immunofluorescence-based flow cytometry assays for monitoring the cellular activation of P-TEFb and HIV latency reversal in cultured primary T cells. Since 2019, my research has been partially supported by two developmental grants (as PI) from the CWRU and Rustbelt Centers for HIV/AIDS Research as well as an R01 grant (as MPI) from NIH/NIAID. Recently, my NIH R01 proposal titled “Cellular mechanisms promoting early reactivation of latent HIV across clades” was approved for funding. Among its objectives, this R01 research will test the efficacy of a novel two-pronged latency reversal strategy to simultaneously activate the initiation and elongation steps of latent HIV transcription.
I’m a basic science researcher with more than 15 years of experience investigating the virus-host interactions and signaling pathways essential for the emergence of HIV from latency in primary T cells. My major research accomplishments over the last 10 years have been: 1) Delineation of the signaling pathways in primary T cells and intermolecular interactions that critically regulate the biogenesis of P-TEFb, a transcription elongation factor necessary for stimulating HIV transcription elongation; 2) Mechanistic characterization of RasGRP1 agonists as a novel class of agents that can reverse HIV latency with minimal undesirable cellular responses; and 3) Development of immunofluorescence-based flow cytometry assays for monitoring the cellular activation of P-TEFb and HIV latency reversal in cultured primary T cells. Since 2019, my research has been partially supported by two developmental grants (as PI) from the CWRU and Rustbelt Centers for HIV/AIDS Research as well as an R01 grant (as MPI) from NIH/NIAID. Recently, my NIH R01 proposal titled “Cellular mechanisms promoting early reactivation of latent HIV across clades” was approved for funding. Among its objectives, this R01 research will test the efficacy of a novel two-pronged latency reversal strategy to simultaneously activate the initiation and elongation steps of latent HIV transcription.